tirzepatide hormone FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 receptors - Eli Lilly Most weight loss medications work

These liposomes are made from phospholipids, the same material that forms your cell membranes

They are not temporary interventions

CJC-1295 DAC provides sustained GHRH receptor activation

"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." December 11, 2025

Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A et al (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

Importantly, this trial compared orforgliprin with oral semaglutide doses that were based on those that are currently available for Rybelsus, but the maximum effective dose offered for the recently approved Wegovy pill for obesity is 25 mg